Industrial - Distribution
Build Your Comparison
Side-by-side financial analysisStock Comparison
TRNS vs SPXC vs NVST
Revenue, margins, valuation, and 5-year total return — side by side.
Industrial - Machinery
Medical - Equipment & Services
TRNS vs SPXC vs NVST — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||
|---|---|---|---|
| Industry | Industrial - Distribution | Industrial - Machinery | Medical - Equipment & Services |
| Market Cap | $852M | $11.54B | $4.01B |
| Revenue (TTM) | $333M | $2.35B | $2.81B |
| Net Income (TTM) | $7M | $254M | $68M |
| Gross Margin | 32.6% | 37.7% | 55.1% |
| Operating Margin | 4.1% | 16.9% | 9.0% |
| Forward P/E | 51.9x | 28.7x | 17.2x |
| Total Debt | $129M | $498M | $1.71B |
| Cash & Equiv. | $5M | $364M | $1.21B |
TRNS vs SPXC vs NVST — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jun 20 | Jun 26 | Return |
|---|---|---|---|
| Transcat, Inc. (TRNS) | 100 | 352.9 | +252.9% |
| SPX Technologies, I… (SPXC) | 100 | 559.1 | +459.1% |
| Envista Holdings Co… (NVST) | 100 | 116.6 | +16.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: TRNS vs SPXC vs NVST
Each card shows where this stock fits in a portfolio — not just who wins on paper.
TRNS is the clearest fit if your priority is income & stability and growth exposure.
- Dividend streak 0 yrs, beta 1.35
- Rev growth 19.2%, EPS growth -63.7%, 3Y rev CAGR 12.9%
- 19.2% revenue growth vs NVST's 8.3%
SPXC has the current edge in this matchup, primarily because of its strength in long-term compounding and sleep-well-at-night.
- 14.3% 10Y total return vs TRNS's 7.7%
- Lower volatility, beta 1.38, Low D/E 22.3%, current ratio 2.48x
- PEG 1.51 vs NVST's 11.50
NVST is the clearest fit if your priority is value.
- Lower P/E (17.2x vs 51.9x)
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 19.2% revenue growth vs NVST's 8.3% | |
| Value | Lower P/E (17.2x vs 51.9x) | |
| Quality / Margins | 10.8% margin vs TRNS's 2.0% | |
| Stability / Safety | Beta 1.35 vs NVST's 1.45, lower leverage | |
| Dividends | Tie | None of these 3 stocks pay a meaningful dividend |
| Momentum (1Y) | +44.9% vs TRNS's +17.9% | |
| Efficiency (ROA) | 7.1% ROA vs NVST's 1.2%, ROIC 13.4% vs 4.8% |
TRNS vs SPXC vs NVST — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
TRNS vs SPXC vs NVST — Financial Metrics
Side-by-side numbers across 3 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
SPXC leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
NVST is the larger business by revenue, generating $2.8B annually — 8.4x TRNS's $333M. SPXC is the more profitable business, keeping 10.8% of every revenue dollar as net income compared to TRNS's 2.0%. On growth, SPXC holds the edge at +17.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||
|---|---|---|---|
| RevenueTrailing 12 months | $333M | $2.3B | $2.8B |
| EBITDAEarnings before interest/tax | $40M | $492M | $342M |
| Net IncomeAfter-tax profit | $7M | $254M | $68M |
| Free Cash FlowCash after capex | $20M | $385M | $220M |
| Gross MarginGross profit ÷ Revenue | +32.6% | +37.7% | +55.1% |
| Operating MarginEBIT ÷ Revenue | +4.1% | +16.9% | +9.0% |
| Net MarginNet income ÷ Revenue | +2.0% | +10.8% | +2.4% |
| FCF MarginFCF ÷ Revenue | +5.9% | +16.4% | +7.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | +15.8% | +17.4% | +14.4% |
| EPS Growth (YoY)Latest quarter vs prior year | -56.3% | +8.2% | +130.0% |
Valuation Metrics
NVST leads this category, winning 5 of 7 comparable metrics.
Valuation Metrics
At 45.5x trailing earnings, SPXC trades at a 72% valuation discount to TRNS's 160.1x P/E. Adjusting for growth (PEG ratio), SPXC offers better value at 2.39x vs NVST's 58.84x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||
|---|---|---|---|
| Market CapShares × price | $852M | $11.5B | $4.0B |
| Enterprise ValueMkt cap + debt − cash | $976M | $11.7B | $4.5B |
| Trailing P/EPrice ÷ TTM EPS | 160.11x | 45.46x | 87.86x |
| Forward P/EPrice ÷ next-FY EPS est. | 51.85x | 28.68x | 17.18x |
| PEG RatioP/E ÷ EPS growth rate | — | 2.39x | 58.84x |
| EV / EBITDAEnterprise value multiple | 24.76x | 23.18x | 13.19x |
| Price / SalesMarket cap ÷ Revenue | 2.57x | 5.10x | 1.47x |
| Price / BookPrice ÷ Book value/share | 2.83x | 4.99x | 1.34x |
| Price / FCFMarket cap ÷ FCF | 43.60x | 47.86x | 17.40x |
Profitability & Efficiency
SPXC leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
SPXC delivers a 12.4% return on equity — every $100 of shareholder capital generates $12 in annual profit, vs $2 for NVST. SPXC carries lower financial leverage with a 0.22x debt-to-equity ratio, signaling a more conservative balance sheet compared to NVST's 0.55x. On the Piotroski fundamental quality scale (0–9), NVST scores 7/9 vs SPXC's 5/9, reflecting strong financial health.
| Metric | |||
|---|---|---|---|
| ROE (TTM)Return on equity | +2.2% | +12.4% | +2.2% |
| ROA (TTM)Return on assets | +1.4% | +7.1% | +1.2% |
| ROICReturn on invested capital | +2.6% | +13.4% | +4.8% |
| ROCEReturn on capital employed | +3.3% | +14.0% | +4.9% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 5 | 7 |
| Debt / EquityFinancial leverage | 0.43x | 0.22x | 0.55x |
| Net DebtTotal debt minus cash | $124M | $134M | $496M |
| Cash & Equiv.Liquid assets | $5M | $364M | $1.2B |
| Total DebtShort + long-term debt | $129M | $498M | $1.7B |
| Interest CoverageEBIT ÷ Interest expense | 2.81x | 10.50x | 12.76x |
Total Returns (Dividends Reinvested)
SPXC leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in SPXC five years ago would be worth $38,893 today (with dividends reinvested), compared to $5,655 for NVST. Over the past 12 months, SPXC leads with a +44.9% total return vs TRNS's +17.9%. The 3-year compound annual growth rate (CAGR) favors SPXC at 39.9% vs NVST's -8.3% — a key indicator of consistent wealth creation.
| Metric | |||
|---|---|---|---|
| YTD ReturnYear-to-date | +59.7% | +13.2% | +13.4% |
| 1-Year ReturnPast 12 months | +17.9% | +44.9% | +30.4% |
| 3-Year ReturnCumulative with dividends | -1.0% | +173.6% | -22.9% |
| 5-Year ReturnCumulative with dividends | +66.3% | +288.9% | -43.4% |
| 10-Year ReturnCumulative with dividends | +769.1% | +1434.7% | -12.0% |
| CAGR (3Y)Annualised 3-year return | -0.3% | +39.9% | -8.3% |
Risk & Volatility
TRNS leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
TRNS is the less volatile stock with a 1.35 beta — it tends to amplify market swings less than NVST's 1.45 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. TRNS currently trades 96.3% from its 52-week high vs NVST's 80.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||
|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.35x | 1.38x | 1.45x |
| 52-Week HighHighest price in past year | $94.76 | $246.68 | $30.42 |
| 52-Week LowLowest price in past year | $50.23 | $152.79 | $18.25 |
| % of 52W HighCurrent price vs 52-week peak | +96.3% | +93.3% | +80.9% |
| RSI (14)Momentum oscillator 0–100 | 62.7 | 61.8 | 54.1 |
| Avg Volume (50D)Average daily shares traded | 155K | 561K | 2.8M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Analyst consensus: TRNS as "Buy", SPXC as "Buy", NVST as "Hold". Consensus price targets imply 35.4% upside for TRNS (target: $124) vs 9.5% for SPXC (target: $252).
| Metric | |||
|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Hold |
| Price TargetConsensus 12-month target | $123.60 | $252.00 | $28.33 |
| # AnalystsCovering analysts | 10 | 12 | 19 |
| Dividend YieldAnnual dividend ÷ price | — | — | — |
| Dividend StreakConsecutive years of raises | 0 | 0 | — |
| Dividend / ShareAnnual DPS | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +0.1% | 0.0% | +4.2% |
SPXC leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). NVST leads in 1 (Valuation Metrics).
TRNS vs SPXC vs NVST: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is TRNS or SPXC or NVST a better buy right now?
For growth investors, Transcat, Inc.
(TRNS) is the stronger pick with 19. 2% revenue growth year-over-year, versus 8. 3% for Envista Holdings Corp (NVST). SPX Technologies, Inc. (SPXC) offers the better valuation at 45. 5x trailing P/E (28. 7x forward), making it the more compelling value choice. Analysts rate Transcat, Inc. (TRNS) a "Buy" — based on 10 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — TRNS or SPXC or NVST?
On trailing P/E, SPX Technologies, Inc.
(SPXC) is the cheapest at 45. 5x versus Transcat, Inc. at 160. 1x. On forward P/E, Envista Holdings Corp is actually cheaper at 17. 2x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: SPX Technologies, Inc. wins at 1. 51x versus Envista Holdings Corp's 11. 50x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — TRNS or SPXC or NVST?
Over the past 5 years, SPX Technologies, Inc.
(SPXC) delivered a total return of +288. 9%, compared to -43. 4% for Envista Holdings Corp (NVST). Over 10 years, the gap is even starker: SPXC returned +1435% versus NVST's -12. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — TRNS or SPXC or NVST?
By beta (market sensitivity over 5 years), Transcat, Inc.
(TRNS) is the lower-risk stock at 1. 35β versus Envista Holdings Corp's 1. 45β — meaning NVST is approximately 8% more volatile than TRNS relative to the S&P 500. On balance sheet safety, SPX Technologies, Inc. (SPXC) carries a lower debt/equity ratio of 22% versus 55% for Envista Holdings Corp — giving it more financial flexibility in a downturn.
05Which is growing faster — TRNS or SPXC or NVST?
By revenue growth (latest reported year), Transcat, Inc.
(TRNS) is pulling ahead at 19. 2% versus 8. 3% for Envista Holdings Corp (NVST). On earnings-per-share growth, the picture is similar: Envista Holdings Corp grew EPS 104. 3% year-over-year, compared to -63. 7% for Transcat, Inc.. Over a 3-year CAGR, SPXC leads at 15. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — TRNS or SPXC or NVST?
SPX Technologies, Inc.
(SPXC) is the more profitable company, earning 10. 8% net margin versus 1. 6% for Transcat, Inc. — meaning it keeps 10. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SPXC leads at 16. 8% versus 4. 0% for TRNS. At the gross margin level — before operating expenses — NVST leads at 55. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is TRNS or SPXC or NVST more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, SPX Technologies, Inc. (SPXC) is the more undervalued stock at a PEG of 1. 51x versus Envista Holdings Corp's 11. 50x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, Envista Holdings Corp (NVST) trades at 17. 2x forward P/E versus 51. 9x for Transcat, Inc. — 34. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for TRNS: 35. 4% to $123. 60.
08Which pays a better dividend — TRNS or SPXC or NVST?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is TRNS or SPXC or NVST better for a retirement portfolio?
For long-horizon retirement investors, SPX Technologies, Inc.
(SPXC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (+1435% 10Y return). Both have compounded well over 10 years (SPXC: +1435%, NVST: -12. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between TRNS and SPXC and NVST?
These companies operate in different sectors (TRNS (Industrials) and SPXC (Industrials) and NVST (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: TRNS is a small-cap high-growth stock; SPXC is a mid-cap quality compounder stock; NVST is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.